valproic acid has been researched along with Brill-Symmers Disease in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with platinum-resistant ovarian cancer (PROC) have limited therapeutic options and poor survival." | 3.11 | Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer. ( Barathi, D; Dahagama, S; Dubashi, B; Ganesan, P; Goenka, L; Kayal, S; Krishnamoorthy, N; Mathaiyan, J; Nakka, T; Thumaty, DB, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakka, T | 1 |
| Goenka, L | 1 |
| Dubashi, B | 1 |
| Kayal, S | 1 |
| Mathaiyan, J | 1 |
| Barathi, D | 1 |
| Krishnamoorthy, N | 1 |
| Thumaty, DB | 1 |
| Dahagama, S | 1 |
| Ganesan, P | 1 |
1 trial available for valproic acid and Brill-Symmers Disease
| Article | Year |
|---|---|
Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Communicable Disease Control; COVID-19; Cytotoxins; Etoposide; Female | 2022 |